热门资讯> 正文
导管精密报告第一季度结果
2026-05-18 20:08
- Catheter Precision press release (VTAK): Q1 revenue grew 200% year-over-year to $432,000, compared to $143,000 in Q1 2025, driven by strong performance in both the Company’s core medical device segment and its newly launched aviation platform.
- Net loss reduced to $1.7 million, compared to $4.0 million in Q1 2025
More on Catheter Precision
- Creatd sells remaining stake in Fly Flyte to Catheter Precision for about $12 mln in cash and equity
- Historical earnings data for Catheter Precision
- Financial information for Catheter Precision
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
